EHMT2 and neuroblastoma: G9a depletion via use of siRNA, or treatment with G9a inhibitors, UNC0638 and UNC0642, reactivates tumor suppressor genes, reduces NB cell proliferation and induces apoptosis, but these effects are observed selectively in cells with MYCN amplification.